USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/9421
TitleEvaluarea proteinei C reactive la pacienţii cu bronhopneumopatie obstructivă cronică în exacerbare
Other TitlesEvaluation of C-reactive protein in patients with chronic obstructive pulmonary disease in exacerbation
AuthorsPopa, Ana
Matcovschi, Sergiu
Caproş, Natalia
Şveţ, Svetlana
Lupan, Mihail
KeywordsChronic obstructive obstructive bronchopneumopathy;reactive C protein;inflammatory marker
Issue Date2018
PublisherAsociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova
CitationPOPA, Ana, MATCOVSCHI, Sergiu, CAPROŞ, Natalia, et al. Evaluarea proteinei C reactive la pacienţii cu bronhopneumopatie obstructivă cronică în exacerbare. In: Arta Medica. 2018, nr. 2(67), pp. 60-62. ISSN 1810-1852.
AbstractScopul studiului a fost de a evalua nivelul proteinei C reactive la pacienţii cu bronhopneumopatie obstructivă cronică în exacerbare. Studiul a fost efectuat pe un lot de 100 de pacienţi cu bronhopneumopatie obstructivă cronică GOLD II-IV în exacerbare, care au fost investigaţi clinic şi paraclinic conform ghidului GOLD 2017. Rezultatele investigației au arătat valori crescute ale CRP la toți pacienții cu bronhopneumopatie obstructivă cronică, predominant la cei cu tipul D și B cu grad sever de boală comparativ cu tipul C. Valoarea crescută a proteinei C reactive la pacienții cu bronhopneumopatie obstructivă cronică poate constitui un factor predictiv pentru o exacerbare severă actuală și fundamenta tratamentul oportun.
The aim of the study was to evaluate the level of C reactive protein in patients with chronic obstructive pulmonary disease in exacerbation. The study was performed on a group of 100 patients with chronic obstructive pulmonary disease GOLD II-IV in exacerbation, that were clinically and paraclinically investigated according to the GOLD 2017 guideline. The results of the study showed elevated C reactive protein values in all patients with chronic obstructive pulmonary disease, predominantly in those with D and B types compared to type C. Increased C reactive protein value in patients with chronic obstructive pulmonary disease may be a predictive factor for a current severe exacerbation and argue the oportun treatment.
URIhttps://artamedica.md/old_issues/ArtaMedica_67.pdf
https://repository.usmf.md/handle/20.500.12710/9421
ISSN1810-1852
Appears in Collections:Arta Medica Vol. 67, No 2, 2018 ediție specială

Files in This Item:
File Description SizeFormat 
EVALUAREA_PROTEINEI_C_REACTIVE_LA_PACIENTII_CU.pdf616.14 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback